ESAB (ESAB) Form 144: 1,440-share insider sale slated for 31 July 2025

Rhea-AI Filing Summary

ESAB Corporation (ESAB) filed a Form 144 indicating that insider Olivier Biebuyck plans to sell up to 1,440 common shares. The proposed sale, to be executed through Fidelity Brokerage Services, is scheduled for 07/31/2025 on the NYSE and is valued at approximately $192,222, implying a per-share price near $133.55. ESAB has roughly 60.6 million shares outstanding, so the notice covers just 0.0024 % of the float and is unlikely to affect market liquidity.

The shares derive from an employee stock option granted 02/24/2020 and exercised on 07/31/2025 for cash. The filing also discloses that Biebuyck sold 1,417 shares on 05/12/2025 for gross proceeds of about $185,847. Combined, the recent and proposed sales total 2,857 shares (~$378 k) but still represent a de minimis ownership change.

No financial performance data or corporate events accompany the notice. Form 144 filings merely signal intent; actual sales may vary or be cancelled. While repeated insider selling can create negative sentiment, the small size relative to ESAB’s market capitalization suggests limited fundamental impact.

Positive

• Sale equals only 0.0024 % of ESAB’s shares outstanding, indicating negligible dilution or market impact.

Negative

• Consecutive insider sales (2,857 shares within three months) may be perceived as a lack of confidence, potentially adding modest negative sentiment.

Insights

Securities Analyst

TL;DR – Very small insider sale; immaterial to valuation but may add mild negative sentiment.

Form 144 shows Olivier Biebuyck intends to sell 1,440 shares worth ~$192k after a similar ~$186k sale in May. Together these disposals equal 0.0047 % of outstanding shares—too small to affect supply-demand dynamics or valuation multiples. The shares stem from option exercises, a routine liquidity event. Investors may watch for patterns—continued insider selling could flag management’s short-term view—but a one-off transaction of this size is generally neutral.

Corporate Governance Expert

TL;DR – Filing complies with Rule 144; no governance red flags detected.

The notice lists broker, share count, acquisition source and Rule 10b5-1 representation, satisfying disclosure requirements. Timing aligns with option vesting, indicating planned diversification rather than strategic exit. No undisclosed adverse information is asserted. Governance impact: neutral; oversight mechanisms appear functional.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1440	192222.43	60622892	07/31/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/31/2025	Option Granted - 02/24/2020	Issuer			1440	07/31/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Olivier Biebuyck 909 Rose Avenue 8th Floor North Bethesda MD 20852	Common	05/12/2025	1417	185846.64

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ESAB shares are being sold under this Form 144?

The filing covers 1,440 common shares, valued at about $192,222.

Who is the seller named in ESAB’s July 2025 Form 144?

The seller is Olivier Biebuyck, whose relationship to ESAB is not specified in the excerpt but is an insider for Rule 144 purposes.

When is the planned sale date for the ESAB shares?

The approximate sale date disclosed is 07/31/2025.

What percentage of ESAB’s outstanding shares does the sale represent?

Only about 0.0024 % of the 60,622,892 shares outstanding.

Were any ESAB shares sold recently by the same insider?

Yes. On 05/12/2025 the insider sold 1,417 shares for gross proceeds of roughly $185,847.

Where will the ESAB shares be sold?

The sale is planned for the NYSE through Fidelity Brokerage Services LLC.